Antenatal betamethasone and the risk of neonatal hypoglycemia: it's all about timing.
Yaniv ZiporiRagda ZidanRoy LauterbachArin HagagYuval GinsbergIdo SoltZeev WeinerAmir KugelmanRon BelooseskyPublished in: Archives of gynecology and obstetrics (2020)
The "time during the day" when betamethasone administered is important when considering the risk for neonatal hypoglycemia. The risk was significantly higher when betamethasone was administered during the peak time and significantly lower when administered at the nadir time of maternal endogenous corticosteroid activity.